见证历史，中国“灯塔工厂”全球霸榜

Core Insights - The "14th Five-Year Plan" period is a milestone for China's technological innovation development, with significant improvements in innovation capabilities and foundational support for becoming a technology powerhouse [1][3] Investment and R&D - By 2024, China's total R&D investment is expected to exceed 3.6 trillion yuan, a 48% increase from 2020, with an R&D intensity of 2.68%, surpassing the EU average [1] - Basic research funding will reach 249.7 billion yuan in 2024, representing over a 70% increase from 2020, with China leading in high-level international journal publications and patent applications for five consecutive years [1] Industry Transformation - The country is accelerating the transformation of traditional industries towards high-end, intelligent, and green development, focusing on key technologies in advanced manufacturing and high-end equipment [4] - The "Jinghua" shield machine set a record by tunneling 542 meters in a month, and the domestically designed "Dream" deep-sea drilling vessel has been successfully launched [4] Emerging Industries - Continuous integration of technology and industry has led to breakthroughs in new-generation information technology and renewable energy, fostering the growth of emerging industries [5] - Approximately 4.6 million 5G base stations have been established, maintaining global leadership in technology and user numbers [6] Environmental and Agricultural Innovations - Significant advancements in environmental protection have led to an 18% reduction in PM2.5 concentration in the Beijing-Tianjin-Hebei region [8] - The use of molecular design breeding technology has resulted in the development of major crop varieties, enhancing disease resistance and yield [8] Transportation and Healthcare - Breakthroughs in transportation technology include the CR450 train achieving speeds of 400 km/h and the C919 aircraft receiving over 1,000 domestic and international orders [9] - Innovations in healthcare include the development of the world's first 5.0T full-body MRI scanner and a dual-antibody drug for cancer treatment, which has been included in the national medical insurance directory [10]